F. Castelnuovo

发表

Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens

F. T. P. Group, C. Torti, G. Carosi, 2007, Drug safety.

Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.

F. Donato, F. Castelli, A. Gori, 2016, The Journal of antimicrobial chemotherapy.

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir

G. di Perri, A. Calcagno, F. Castelli, 2018, Antimicrobial Agents and Chemotherapy.

Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience

S. Lonardi, F. Facchetti, G. Rossi, 2015, Leukemia & lymphoma.

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

R. Maserati, A. Lazzarin, A. Antinori, 2009, Infection.

A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.

C. Tinelli, A. Antinori, A. De Luca, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection

M. Puoti, E. Cariani, F. Castelnuovo, 1992, Hepatology.

Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.

S. Di Giambenedetto, C. Torti, N. Manca, 2007, AIDS patient care and STDs.

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function

S. Di Giambenedetto, C. Torti, E. Quiros-Roldan, 2016, The open AIDS journal.

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia

F. Castelli, A. Matteelli, G. Cristini, 2020, Infection.

Analysis of the hepatitis B virus genome and immune response in HBsAg, anti-HBs positive chronic hepatitis.

F. Ghiotto, D. Primi, E. Cariani, 1994, Journal of hepatology.

Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.

F. Castelli, A. Matteelli, G. Carosi, 1996, The American journal of tropical medicine and hygiene.

Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously

M. Puoti, C. Mazza, A. Albertini, 1996, Journal of medical virology.

Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).

S. Leone, S. Lo Caputo, F. Mazzotta, 2015, International journal of epidemiology.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

C. Torti, G. Carosi, E. Quiros-Roldan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A case of cryptococcal meningoencephalitis and focal cerebral vasculitis with transient immunodeficiency.

G. Cristini, F. Castelnuovo, A. Scalzini, 1990, Acta neurologica.

Influence of Hepatitis C Genotypes on Lipid Levels in HIV-Positive Patients during Highly Active Antiretroviral Therapy

C. Tinelli, R. Maserati, C. Torti, 2005, Antiviral therapy.

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

S. Di Giambenedetto, C. Torti, M. Fabbiani, 2012, AIDS Research and Therapy.

Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study

F. Donato, F. Castelli, A. Bandera, 2015, Journal of acquired immune deficiency syndromes.

Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications

C. Torti, I. Izzo, N. Manca, 2010, Epidemiology and Infection.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009

F. Castelli, C. Torti, A. Vavassori, 2012, International journal of STD & AIDS.

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection

R. Maserati, G. Nunnari, C. Sagnelli, 2017, PloS one.

No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients.

C. Tinelli, P. Arosio, C. Torti, 2007, Journal of Acquired Immune Deficiency Syndromes.

The evolving burden of HIV infection compared with other chronic diseases in northern Italy *

M. Magoni, D. Bishai, C. Torti, 2011, HIV medicine.

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study

F. Donato, A. Bandera, E. Raffetti, 2017, BMC Infectious Diseases.

Male breast cancer in an HIV-infected patient: a case report.

E. Quiros-Roldan, F. Castelnuovo, A. Ferraresi, 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

Updated prevalence of genotypic resistance among HIV‐1 positive patients naïve to antiretroviral therapy: a single center analysis

Carlo Torti, C. Torti, I. Izzo, 2008, Journal of medical virology.

Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study

M. Magoni, F. Donato, F. Castelli, 2016, PloS one.

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

F. Castelli, A. Gori, C. Torti, 2016, BMC Public Health.

The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study

F. Donato, F. Castelli, A. Bandera, 2015, Journal of Translational Medicine.

Evolution of Antiretroviral Prescription and Response over a Period of 8 years: an Italian Multicentre Observational Prospective Cohort Study

C. Tinelli, C. Torti, G. Carosi, 2008, Infection.

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study

F. Donato, M. Fabbiani, E. Raffetti, 2015, BMC Public Health.

Prevalence and Risk Factors for Etravirine Resistance among Patients Failing on Non-Nucleoside Reverse Transcriptase Inhibitors

C. Torti, N. Manca, G. Carosi, 2008, Antiviral therapy.

Short communication Prevalence and risk factors for etravirine resistance among patients failing on non-nucleoside reverse transcriptase inhibitors

C. Torti, N. Manca, G. Carosi, 2008 .

Reply to van der Pas et al

C. Torti, G. Carosi, E. Quiros-Roldan, 2011 .

The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study

F. Donato, F. Castelli, A. Bandera, 2015, Journal of Translational Medicine.